-
No fish to eat will cause malnutrition
Time of Update: 2021-06-16
Shahid Naeem, co-author of the study and director of Columbia University’s Center for Sustainable Research on the Earth’s Environment, said: “Different types of plants and animals contain different nutrients, so biodiversity is the key to adequate human nutrition .
-
Announcement of 27 China Analysis and Testing Association 2021 BCEIA Gold Award Application Projects
Time of Update: 2021-06-10
According to the "China Analysis and Testing Association Science and Technology Award-Analysis and Testing Technology Award (BCEIA Gold Award) Selection Method", all have passed the formal review.
-
For severe alopecia areata, Zejing Pharmaceutical's JAK inhibitor initiates Phase 3 clinical trials
Time of Update: 2021-06-10
On June 2, the China Drug Clinical Trial Registration and Information Disclosure Platform showed that Zejing Pharmaceuticals launched a Phase 3 clinical trial of Jacketinib Hydrochloride Tablets for the treatment of severe alopecia areata .
-
Amgen's innovative first-line treatment for gastric cancer reduces the risk of death by 40%
Time of Update: 2021-06-10
5 months, the median overall survival (OS) of patients with FGFR2b positive and HER2-negative gastric cancer or gastroesophageal junction cancer (GEJ) who received bemarituzumab and chemotherapy as first-line treatment was 19.
-
Domestic innovative drugs are emerging, and local innovative drugs are selected for the first time in the plenary meeting
Time of Update: 2021-06-10
According to Junshi Bio's press release, JUPITER-02 is currently the world's largest phase 3 clinical study of immune checkpoint inhibitor combined with chemotherapy for the first-line treatment of recurrent or metastatic nasopharyngeal carcinoma.
-
Countdown 100 days to the 6th Guangzhou International Biotechnology Conference and Exhibition
Time of Update: 2021-06-08
In order to enrich the participation experience of exhibitors and professional visitors, and strengthen the stickiness with the organizing committee, the organizer of the BTE Guangzhou International Biotechnology Conference specially organized the "Registration and Visiting Lottery Draw" and "Check-in and Appreciation Activities" on the 100-day countdown to the exhibition.
-
Which ADC pipeline layout is strong? Look at the first Sankyo
Time of Update: 2021-06-08
Dato-DXd is an antibody-conjugated drug (ADC) targeting TROP2 for the treatment of patients with advanced or metastatic non-small cell lung cancer (NSCLC) and triple negative breast cancer (TNBC) whose genome has not changed.
-
6-hour installation + negative pressure environment "Falcon" air film shelter laboratory completed in Guangzhou
Time of Update: 2021-06-08
"Falcon" air film shelter laboratory is composed of Guangzhou Laboratory and National Respiratory Center, National Respiratory Diseases Clinical Medicine Research Center, State Key Laboratory of Respiratory Diseases, First Affiliated Hospital of Guangzhou Medical University, Guangzhou Respiratory Health Research Institute, Jinyu Medical, MGI and other units jointly built, among them, this set of hard gas nucleic acid testing laboratory that can realize fast installation and negative pressure environment is from MGI.
-
Simcere cooperates with Boao Hengda to use Trilaciclib for the first time in clinical treatment
Time of Update: 2021-06-08
It was approved by the Hainan Provincial Drug Administration to be used for the first clinical treatment of patients with extensive-stage small cell lung cancer (ES-SCLC) in Boao Evergrande International Hospital.
-
BYK Precision series gas generators: expand and contract freely, as you control
Time of Update: 2021-06-08
Booth photos BYK Precision series gas generators can provide nitrogen, helium, or zero-grade air for thousands of GC applications around the world, which can be used as carrier gas and detector gas to meet the gas requirements of specific GC applications in the laboratory.
-
Condolences!
Time of Update: 2021-06-04
In 2013, he served as the chief of the National 863 Program "Key Technologies for the Localization of Protein Sequencing Equipment and Related Reagents" A scientist, his laboratory has developed various types of mass spectrometers such as Q-TOF, quadrupole, ion trap, etc.
-
Epidemic notification on May 30: 20 new cases in Guangdong required nucleic acid certificate within 72 hours to leave the ear
Time of Update: 2021-06-04
More than 10,000 new confirmed cases in the United States in a single day US media: The United States has pledged 80 million doses of vaccine to support overseas and has not issued a dose so far According to Worldometer's real-time statistics, as of about 6:30 on May 31st, Beijing time, a total of 34,042,859 cases of new coronary pneumonia have been confirmed in the United States, and a total of 609,541 deaths have been reported.
-
New drugs approved before May 31 will receive a patent-free compensation period!
Time of Update: 2021-06-04
Article 42 Paragraph 3 of the revised Patent Law stipulates that, in order to compensate for the time taken by the new drug marketing review and approval, the State Intellectual Property Office shall grant a patent at the request of the patentee for the new drug-related invention patents that have been approved for marketing in China.
-
2021 Biotherapy Industry Conference
Time of Update: 2021-06-04
3. Introduction to the conferenceIn order to promote the basic research of my country's biotherapy, the industrialization of new technologies and clinical applications, we will build a communication platform for researchers, R&D companies and clinicians, analyze research hotspots and policy standards at home and abroad, and discuss global market trends and business development Direction, the 2021 Biotherapy Industry Conference will be held in Shanghai from June 19-20.
-
NICE approves Johnson & Johnson Tremfya to treat active psoriatic arthritis
Time of Update: 2021-06-04
(Sina Pharmaceutical News) Reference source: NICE green lights Tremfya to treat active psoriatic arthritis A few days ago, Johnson & Johnson Xian Janssen IL-23 inhibitor Tremfya has been included in the NHS of the British healthcare system by the National Institute of Health and Care Excellence (NICE) for the treatment of active psoriatic arthritis (PsA).
-
"Dried" this bowl of sports "cocktail"
Time of Update: 2021-06-04
Those who spend only a few minutes engaged in moderate to vigorous physical activity can reduce their risk of premature death by 30% as long as they spend another 6 hours engaged in light activity.
-
A new method for detecting autoimmune diseases by ferritin multimeric antigen-antibody
Time of Update: 2021-06-04
In order to improve the efficiency of diagnosis of autoimmune diseases, China Kexue Yuan academician , Zhong Keyuan researcher at the Institute of Biophysics Xiyun Yan teamwork with Professor People's Hospital of Peking University, Li Zhan-guo team, with pSS as a research model to develop a showcase poly-antigen based on ferritin and The new method of detecting autoantibodies by poly-second antibodies increases the sensitivity of detection by 100-1000 times.
-
Gastric cancer anti-tumor immune "super soldier" cells were discovered
Time of Update: 2021-06-04
Gastric cancer anti-tumor immune "super soldier" cells were discovered Gastric cancer anti-tumor immune "super soldier" cells were discovered Gastric cancer anti-tumor immune "super
-
Play games to treat ADHD, digital therapy cutting-edge raises $160 million in financing
Time of Update: 2021-06-04
Akili Interactive is developing a video game that has been clinically proven to improve cognitive functions.
Retrieved 2021-05-27, from https:// game-treatment-for-adhdAkili Interactive is developing a video game that has been clinically proven to improve cognitive functions.
-
US Food and Drug Administration approves Johnson & Johnson's Rybrevant
Time of Update: 2021-05-31
S. Food and Drug Administration (FDA) has approved Johnson & Johnson's Rybrevant as the first treatment for advanced non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) exon 20 insertion mutations.
